The move by Eli Lilly came less than 24 hours after Johnson & Johnson paused further dosing in all of its COVID-19 vaccine candidate clinical trials while it investigated a volunteer’s illness.
(Image credit: Cheryl Gerber/AP)
Johnson & Johnson, Eli Lilly Pause COVID-19 Drug Trials
Tweet on Twitter
Share on Facebook
Google+
Pinterest
